Samar A. Antar
Impact in
-
- Natural Antidiabetic Agents Studies
-
- Phytochemicals and Antioxidant Activities
Papers in
-
- Chemotherapy-induced cardiotoxicity and mitigation 3
- Co-authors
- Ahmed A. Al‐Karmalawy (13 shared papers)Nada A. Ashour (2 shared papers)Mohamed A. Saleh (7 shared papers)Ahmed Elkamhawy (2 shared papers)Muhammad Khattab (1 shared paper)Eun Joo Roh (1 shared paper)Marwa Sharaky (1 shared paper)Mona F. El-Azab (3 shared papers)
- Journals
- Life Sciences (8 papers)Pharmaceuticals (1 paper)Environmental Science and Pollution Research (1 paper)Vaccines (1 paper)International Immunopharmacology (1 paper)
- Partner nations
- EgyptUnited StatesSaudi Arabia
In The Last Decade
Samar A. Antar
23 papers receiving 905 citations
Samar A. Antar's Hit Papers
Peers
Comparison fields: 5 of 101
- Endocrinology, Diabetes and Metabolism 117
- Biochemistry 32
- Pharmacology 40
- Clinical Biochemistry 26
- Nephrology 25
Countries citing papers authored by Samar A. Antar
This map shows the geographic impact of Samar A. Antar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samar A. Antar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samar A. Antar more than expected).
Fields of papers citing papers by Samar A. Antar
This network shows the impact of papers produced by Samar A. Antar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samar A. Antar. The network helps show where Samar A. Antar may publish in the future.
Co-authors
The 25 scholars most cited alongside Samar A. Antar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments Hit paper breakdown → | 2023 | 268 |
| 2 | Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation Hit paper breakdown → | 2023 | 194 |
| 3 | 2021 | 55 | |
| 4 | 2022 | 51 | |
| 5 | 2022 | 43 | |
| 6 | 2021 | 42 | |
| 7 | 2021 | 37 | |
| 8 | 2022 | 36 | |
| 9 | 2023 | 35 | |
| 10 | 2020 | 28 | |
| 11 | 2023 | 21 | |
| 12 | 2021 | 17 | |
| 13 | 2022 | 16 | |
| 14 | 2024 | 13 | |
| 15 | 2022 | 13 | |
| 16 | 2021 | 11 | |
| 17 | 2023 | 8 | |
| 18 | 2022 | 8 | |
| 19 | 2022 | 8 | |
| 20 | 2023 | 5 |
About Samar A. Antar
Samar A. Antar is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Health, Toxicology and Mutagenesis and Genetics, having authored 24 papers that have together received 917 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Heavy Metal Exposure and Toxicity (2 papers), Inflammatory Bowel Disease (2 papers), Diabetes Management and Research (1 paper), Phytochemicals and Antioxidant Activities (1 paper) and Click Chemistry and Applications (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (117 citations), Biochemistry (32 citations), Pharmacology (40 citations), Clinical Biochemistry (26 citations) and Nephrology (25 citations). Samar A. Antar has collaborated with scholars based in Egypt, United States and Saudi Arabia. Frequent co-authors include Ahmed A. Al‐Karmalawy, Nada A. Ashour, Mohamed A. Saleh, Ahmed Elkamhawy, Muhammad Khattab, Eun Joo Roh, Marwa Sharaky, Mona F. El-Azab, Reem M. Hazem and Walied Abdo. Their work appears in journals such as Life Sciences, Pharmaceuticals, Environmental Science and Pollution Research, Vaccines and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.